Protective effects of vitamin E against hypercholesterolemia-induced age-related diseases

Genes and Nutrition

Volumn 7, Issue 1, 2012, Pages 91-98

  Catalgol, Betul ^a   Ozer, Nesrin Kartal ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

Alzheimer's disease; Atherosclerosis; Hypercholesterolemia; Tocotrienol; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CHOLESTEROL;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ATHEROGENIC DIET; ATHEROSCLEROSIS; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; CONFERENCE PAPER; DIETARY INTAKE; DRUG MECHANISM; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; LIPID METABOLISM; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROTECTION; RISK FACTOR; SMOOTH MUSCLE FIBER;

EID: 84860746007     PISSN: 15558932     EISSN: 18653499     Source Type: Journal    
DOI: 10.1007/s12263-011-0235-9     Document Type: Conference Paper

References (109)

1. Adachi H, Ishii N (2000) Effects of tocotrienols on life span and protein carbonylation in Caenorhabditis elegans. J Gerontol A 55(6):B280-B285 (Pubitemid 30368403)
2. Ascherio A, Rimm E, Hernan MA, Giovannucci E, Kawachi I, Stampfer MJ et al (1999) Relation of consumption of vitamin E, vitamin C, and carotenoids to risk for stroke among men in the United States. Ann Intern Med 130(12):963-970 (Pubitemid 29283986)
3. Aytan N, Jung T, Tamturk F, Grune T, Kartal Ozer N (2008) Oxidative stress related changes in the brain of hypercholesterolemic rabbits. Biofactors 33:225-236
4. Azzi A, Boscoboinik D, Marilley D, Ozer NK, Stauble B, Tasinato A (1995) Vitamin E: a sensor and an information transducer of the cell oxidation state. Am J Clin Nutr 62(6 Suppl):1337S-1346S
5. Balazs L, Leon M (1994) Evidence of an oxidative challenge in the Alzheimer's brain. Neurochem Res 19:1131-1137 (Pubitemid 24284787)
6. Black TM, Wang P, Maeda N, Coleman RA (2000) Palm tocotrienols protect ApoE± mice from diet-induced atheroma formation. J Nutr 130(10):2420-2426
7. Bocan TM, Mueller SB, Mazur MJ, Uhlendorf PD, Brown EQ, Kieft KA (1993) The relationship between the degree of dietaryinduced hypercholesterolemia in the rabbit and atherosclerotic lesion formation. Atherosclerosis 102:9-22 (Pubitemid 23269727)
8. Burton GW, Ingold KU (1989) Vitamin E as an in vitro and in vivo antioxidant. Ann N Y Acad Sci 570:7-22 (Pubitemid 20103380)
9. Butterfield DA, Martin L, Carney JM, Hensley K (1996) A beta (25-35) peptide displays H2O2-like reactivity towards aqueous Fe2?, nitroxide spin probes, and synaptosomal membrane proteins. Life Sci 58:217-228
10. Cash AD, Perry G, Smith MA (2002) Therapeutic potential in Alzheimer disease. Curr Med Chem 9:1605-1610
11. Catalgol B, Grune T (2009) Protein pool maintenance during oxidative stress. Curr Pharm Des 15(26):3043-3051
12. Catalgol B, Özer NK (2010) Lipid rafts and redox regulation of cellular signaling in cholesterol induced atherosclerosis. Curr Cardiol Rev 6(4):309-324
13. Chitu V, Stanley ER (2006) Colony-stimulating factor-1 in immunity and inflammation. Curr Opin Immunol 18:39-48 (Pubitemid 43049646)
14. Cordero Z, Drogan D, Weikert C, Boeing H (2010) Vitamin E and risk of cardiovascular diseases: a review of epidemiologic and clinical trial studies. Crit Rev Food Sci Nutr 50(5):420-440
15. Das DK (2010) Redox signaling via lipid rafts. In: Dipak Das (ed) Methods in redox signaling. Mary Ann Liebert, p 156-158
16. Fan J, Watanabe T (2003) Inflammatory reactions in the pathogenesis of atherosclerosis. J Atheroscler Thromb 10:63-71
17. Feng J, Han J, Pearce SFA, Silverstein RL, Gotto AM, Hajjar DP et al (2000) Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma. J Lipid Res 41:688-696
18. Fortuno A, Jose GS, Moreno MU, Diez J, Zalba G (2005) Oxidative stress and vascular remodelling. Exp Physiol 90:457-462 (Pubitemid 40980145)
19. Francis PT, Palmer AM, Snape M, Wilcock GK (1999) The cholinergic hypothesis of Alzheimer's disease: a review of progress. J Neurol Neurosurg Psychiat 66:137-147 (Pubitemid 29103513)
20. Galbusera C, Facheris M, Magni F, Galimberti G, Sala G, Tremolada L et al (2004) Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients. Curr Alzheimer Res 1:103-109
21. Gey KF (1995) Ten-year retrospective on the antioxidant hypothesis of arteriosclerosis: Threshold plasma levels of antioxidant micronutrients related to minimum cardiovascular risk. J Nutr Biochem 6:206-236
22. Good PF, Perl DP, Bierer LM, Schmeidler J (1992) Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann Neurol 31(3):286-292
23. Good PF, Werner P, Hsu A, Olanow CW, Perl DP (1996) Evidence of neuronal oxidative damage in Alzheimer's disease. Am J Pathol 149(1):21-28 (Pubitemid 26230974)
24. Green J, Bunyan J (1969) Vitamin E and the biological antioxidant theory. Nutr Abst Rev 39(2):321-345
25. Griffiths HR, Moller L, Bartosz G, Bast A, Bertoni-Freddari C, Collins A, Cooke M, Coolen S, Haenen G, Hoberg AM, Loft S, Lunec J, Olinski R, Parry J, Pompella A, Poulsen H, Verhagen H, Astley SB (2002) Biomarkers. Mol Aspects Med 23(1-3):101-208 (Pubitemid 34669882)
26. Grodstein F, Chen J, Willett WC (2003) High-dose antioxidant supplements and cognitive function in community-dwelling elderly women. Am J Clin Nutr 77:975-984
27. Guyton JR, Bocan TM, Schifani TA (1985) Quantitative ultrastructural analysis of perifibrous lipid and its association with elastin in nonatherosclerotic human aorta. Arteriosclerosis 5:644-652 (Pubitemid 16170859)
28. Harizi H, Gualde N (2006) Pivotal role of PGE2 and IL-10 in the cross-regulation of dendritic cell-derived inflammatory mediators. Cell Mol Immunol 3:271-277
29. Hensley K, Carney JM, Mattson MP, Aksenova M, Harris M, Wu JF et al (1994) A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc Natl Acad Sci USA 91(8):3270-3274
30. Hensley K, Hall N, Subramaniam R, Cole P, Harris M, Aksenov M et al (1995) Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J Neurochem 65:2146-2156
31. Hensley K, Maidt ML, Yu Z, Sang H, Markesbery WR, Floyd RA (1998) Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J Neurosci 18:8126-8132 (Pubitemid 28464991)
32. Hirvonen T, Virtamo J, Korhonen P, Albanes D, Pietinen P (2000) Intake of flavonoids, carotenoids, vitamins C and E, and risk of stroke in male smokers. Stroke 31(10):2301-2306
33. Kamat CD, Gadal S, Mhatre M, Williamson KS, Pye QN, Hensley K (2008) Antioxidants in central nervous system diseases: preclinical promise and translational challenges. J Alzheimers Dis 15(3):473-493
34. Kaul N, Devaraj S, Jialal I (2001) Alpha-tocopherol and atherosclerosis. Exp Biol Med 226:5-12
35. Keli SO, Hertog M, Feskens EJ, Kromhout D (1996) Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen study. Arch Intern Med 156(6):637-642 (Pubitemid 26095013)
36. Keller JN, Schmitt FA, Scheff SW, Ding Q, Chen Q, Butterfield DA et al (2005) Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 64:1152-1156
37. Knekt P, Reunanen A, Jarvinen R, Seppanen R, Heliovaara M, Aromaa A (1994) Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol 139(12):1180-1189 (Pubitemid 24184411)
38. Kushi LH, Folsom A, Prineas RJ, Mink PJ, Wu Y, Bostick RM (1996) Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 334(18): 1156-1162 (Pubitemid 26137974)
39. Laurin D, Masaki KH, Foley DJ, White LR, Launer LJ (2004) Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia aging study. Am J Epidemiol 159:959-967 (Pubitemid 38608273)
40. Ledesma MD, Bonay P, Colaco C, Avila J (1994) Analysis of microtubule-associated protein tau glycation in paired helical filaments. J Biol Chem 269(34):21614-21619 (Pubitemid 24274797)
41. Lovell MA, Ehmann WD, Markesbery WR (1997) Elevated 4-hydroxynonenal in ventricular fluid in alzheimer's disease. Neurobiol Aging 18(5):457-461 (Pubitemid 27497140)
42. Luchsinger JA, Tang MX, Shea S, Mayeux R (2003) Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol 60:203-208 (Pubitemid 36193963)
43. Madamanchi NR, Vendrov A, Runge MS (2005) Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 25(1):29-38 (Pubitemid 40054251)
44. Markesbery WR, Lovell MA (2007) Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment. Arch Neurol 64: 954-956 (Pubitemid 47047994)
45. Masaki KH, Losonczy KG, Izmirlian G, Foley DJ, Ross GW, Petrovitch H et al (2000) Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology 54:1265-1272 (Pubitemid 30174045)
46. Masliah E, Alford M, DeTeresa R, Mallory M, Hansen L (1996) Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann Neurol 40:759-766 (Pubitemid 26415188)
47. Mecocci P, MacGarvey U, Beal MF (1994) Oxidative damage to mitochondrial DNA is increased in alzheimer's disease. Ann Neurol 36:747-751 (Pubitemid 24337634)
48. Mishto M, Belavista E, Santoro A, Stolzing A, Ligorio C, Nacmias B et al (2006) Immunoproteasome and LMP2 polymorphism in aged and alzheimer's disease brains. Neurobiol Aging 27:54-66 (Pubitemid 41627950)
49. Montine TJ, Amarnath V, Martin ME, Strittmatter WJ, Graham DG (1996) E-4-hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures. Am J Pathol 148(1):89-93 (Pubitemid 26019647)
50. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Aggarwal N, Wilson RS, Scherr PA (2002) Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA 287:3230-3237 (Pubitemid 34686104)
51. Muntwyler J, Hennekens CH, Manson JE, Buring JE, Gaziano JM (2002) Vitamin supplement use in a low-risk population of US male physicians and subsequent cardiovascular mortality. Arch Intern Med 162(13):1472-1476 (Pubitemid 34747480)
52. Negis Y, Aytan N, Ozer N, Ogru E, Libinaki R, Gianello R et al (2006) The effect of tocopheryl phosphates on atherosclerosis progression in rabbits fed with a high cholesterol diet. Arch Biochem Biophys 450(1):63-66 (Pubitemid 43782742)
53. Nordberg J, Arnér ES (2001) Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 31(11):1287-1312 (Pubitemid 33145299)
54. Nunomura A, Castellani RJ, Zhu X, Moreira PI, Perry G, Smith MA (2006) Involvement of oxidative stres in Alzheimer disease. J Neuropathol Exp Neurol 65:631-641 (Pubitemid 44297254)
55. Osterud B, Bjorklid E (2003) Role of monocytes in atherogenesis. Physiol Rev 83(4):1069-1112 (Pubitemid 37222268)
56. Ozer NK, Palozza P, Boscoboinik D, Azzi A (1993) d-alphatocopherol inhibits low density lipoprotein induced proliferation and protein kinase C activity in vascular smooth muscle cells. FEBS Lett 322(3):307-310 (Pubitemid 23144710)
57. Ozer NK, Sirikci O, Taha S, San T, Moser U, Azzi A (1998) Effect of vitamin E and probucol on dietary cholesterol-induced atherosclerosis in rabbits. Free Radic Biol Med 24(2):226-233 (Pubitemid 28008799)
58. Ozer NK, Negis Y, Aytan N, Villacorta L, Ricciarelli R, Zingg JM et al (2006) Vitamin E inhibits CD36 scavenger receptor expression in hypercholesterolemic rabbits. Atherosclerosis 184(1):15-20 (Pubitemid 41721064)
59. Pappolla MA, Bryant-Thomas TK, Herbert D, Pacheco J, Fabra Garcia M, Manjon M et al (2003) Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology 61(2):199-205 (Pubitemid 36875301)
60. Parker RA, Pearce BC, Clark RW, Gordon DA, Wright JJ (1993) Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutarylcoenzyme A reductase. J Biol Chem 268(15):11230-11238 (Pubitemid 23162316)
61. Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S et al (2005) Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 352:2379-2388 (Pubitemid 40958434)
62. Pixley FJ, Stanley ER (2004) CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol 14:628-638 (Pubitemid 39440612)
63. Prasad K, Mantha S, Kalra J, Lee P (1997) Hypercholesterolemiainduced oxidative stress in heart and its prevention by vitamin E. Int J Angiol 6:13-17 (Pubitemid 26426724)
64. Pratico D, Uryu K, Leight S, Trojanoswki JQ, Lee VM (2001) Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci 21: 4183-4187 (Pubitemid 32538543)
65. Premkumar DR, Smith MA, Richey PL, Petersen RB, Castellani R, Kutty RK et al (1995) Induction of heme oxygenase-1 mRNA and protein in neocortex and cerebral vessels in Alzheimer's disease. J Neurochem 65:1399-1402
66. Qureshi AA, Qureshi N, Wright JJ, Shen Z, Kramer G, Gapor A et al (1991) Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (palmvitee). Am J Clin Nutr 53(4 Suppl):1021S-1026S (Pubitemid 21898866)
67. Qureshi AA, Bradlow BA, Brace L, Manganello J, Peterson DM, Pearce BC et al (1995) Response of hypercholesterolemic subjects to administration of tocotrienols. Lipids 30(12): 1171-1177
68. Qureshi AA, Sami SA, Salser WA, Khan FA (2001a) Synergistic effect of tocotrienol-rich fraction (TRF(25)) of rice bran and lovastatin on lipid parameters in hypercholesterolemic humans. J Nutr Biochem 12(6):318-329 (Pubitemid 32552047)
69. Qureshi AA, Salser WA, Parmar R, Emeson EE (2001b) Novel tocotrienols of rice bran inhibit atherosclerotic lesions in C57BL/ 6 ApoE-deficient mice. J Nutr 131(10):2606-2618 (Pubitemid 32947784)
70. Qureshi AA, Sami SA, Salser WA, Khan FA (2002) Dose-dependent suppression of serum cholesterol by tocotrienol-rich fraction (TRF25) of rice bran in hypercholesterolemic humans. Atherosclerosis 161(1):199-207 (Pubitemid 34214837)
71. Rahaman SO, Lennon DJ, Febbraio M, Podrez EA, Hazen SL, Silverstein RL (2006) A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Cell Metab 4:211-221 (Pubitemid 44283954)
72. Ricciarelli R, Tasinato A, Clément S, Ozer NK, Boscoboinik D, Azzi A (1998) Alpha-tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state. Biochem J 334(Pt 1):243-249 (Pubitemid 28420995)
73. Ricciarelli R, Zingg JM, Azzi A (2000) Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells. Circulation 102(1):82-87 (Pubitemid 30430557)
74. Ricciarelli R, Zingg J, Azzi A (2001) Vitamin E: protective role of a Janus molecule. FASEB J 15(13):2314-2325 (Pubitemid 33063160)
75. Rimm EB, Stampfer M, Ascherio A, Giovannucci E, Colditz GA, Willett WC (1993) Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 328(20):1450-1456 (Pubitemid 23143847)
76. Robbesyn F, Salvayre R, Negre-Salvayre A (2004) Dual role of oxidized LDL on the NF-kappaB signaling pathway. Free Radic Res 38(6):541-551 (Pubitemid 38697088)
77. Salvayre R, Auge N, Benoist H, Negre-Salvayre A (2002) Oxidized low-density lipoprotein-induced apoptosis. Biochim Biophys Acta 1585(2-3):213-221 (Pubitemid 36092085)
78. Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M et al (1997) A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's disease cooperative study. N Engl J Med 336:1216-1222 (Pubitemid 27183651)
79. Sayre LM, Zelasko DA, Haris PL, Perry G, Salomon RG, Smith MA (1997) 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem 68(5):2092-2097 (Pubitemid 27176147)
80. Schmitz G, Grandl M (2007) Role of redox regulation and lipid rafts in macrophages during ox-LDL mediated foam cell formation. Antioxid Redox Signal 9(9):1499-1518 (Pubitemid 47255028)
81. Schuessel K, Schafer S, Bayer TA, Czech C, Pradier L, Muller-Spahn F et al (2005) Impaired Cu/Zn- SOD activity contributes to increased oxidative damage in APP transgenic mice. Neurobiol Dis 18:89-99 (Pubitemid 40092899)
82. Sen CK, Khanna S, Roy S (2006) Tocotrienols: vitamin E beyond tocopherols. Life Sci 78:2088-2098
83. Sirikci O, Ozer NK, Azzi A (1996) Dietary cholesterol induced changes of protein kinase C and the effect of vitamin E in rabbit aortic smooth muscle cells. Atherosclerosis 126:253-263 (Pubitemid 26336662)
84. Smith EB (1974) The relationship between plasma, tissue lipids in human atherosclerosis. Adv Lipid Res 12:1-49
85. Smith CD, Carney JM, Starke-Reed PE, Oliver CN, Stadtman ER, Floyd RA et al (1991) Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci USA 88(23):10540-10543 (Pubitemid 21915871)
86. Smith MA, Taneda S, Richey PL, Miyata S, Yan SD, Stern D et al (1994) Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 91(12):5710-5714 (Pubitemid 24174398)
87. Smith MA, Rudnicka-Nawrot M, Richey PL, Praprotnik D, Mulvihill P, Miller CA et al (1995) Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease. J Neurochem 64(6):2660-2666
88. Squier TC (2001) Oxidative stress and protein aggregation during biological aging. Exp Gerontol 36:1539-1550 (Pubitemid 32768730)
89. Stampfer MJ, Hennenkens C, Manson JE, Colditz GA, Rosner B, Willett WC (1993) Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 328(20):1444-1449 (Pubitemid 23143846)
90. Steinberg D (2009) The LDL modification hypothesis of atherogenesis: an update. J Lipid Res 50:S376-S381
91. Stocker R, Keaney JF Jr (2004) Role of oxidative modifications in atherosclerosis. Physiol Rev 84(4):1381-1478 (Pubitemid 39302636)
92. Stokes KY, Cooper D, Tailor A, Granger DN (2002) Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide. Free Radic Biol Med 33(8):1026-1036
93. Suarna C, Hood RL, Dean RT, Stocker R (1993) Comparative antioxidant activity of tocotrienols and other natural lipidsoluble antioxidants in a homogeneous system, and in rat and human lipoproteins. Biochim Biophys Acta 1166(2-3):163-170 (Pubitemid 23060889)
94. Sultana R, Perluigi M, Butterfield DA (2006) Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurode-generation from redox proteomics. Antioxid Redox Signal 8:2021-2037 (Pubitemid 46499264)
95. Suzuki YJ, Tsuchiya M, Wassall SR, Choo YM, Govil G, Kagan VE et al (1993) Structural and dynamic membrane properties of alpha-tocopherol and alpha-tocotrienol: implication to the molecular mechanism of their antioxidant potency. Biochemistry 32(40):10692-10699 (Pubitemid 23327802)
96. Tan DT, Khor HT, Low WH, Ali A, Gapor A (1991) Effect of a palmoil- vitamin E concentrate on the serum and lipoprotein lipids in humans. J Clin Nutr 53(4 Suppl):1027S-1030S (Pubitemid 21898867)
97. Thomas SR, Neuzil J, Mohr D, Stocker R (1995) Coantioxidants make alpha-tocopherol an efficient antioxidant for low-density lipoprotein. Am J Clin Nutr 62(6 Suppl):1357S-1364S
98. Todd S, Woodward M, Tunstall-Pedoe H, Bolton-Smith C (1999) Dietary antioxidant vitamins and fiber in the etiology of cardiovascular disease and all-causes mortality: results from the Scottish heart health study. Am J Epidemiol 150(10):1073-1080 (Pubitemid 29531943)
99. Traber MG, Atkinson JM (2007) Vitamin E, antioxidant and nothing more. Free Radic Biol Med 43(1):4-15 (Pubitemid 46874839)
100. Uchida K, Shiraishi M, Naito Y, Torii Y, Nakamura Y, Osawa T (1999) Activation of stress signaling pathways by the end product of lipid peroxidation. 4-hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J Biol Chem 274:2234-2242
101. Upston JM, Terentis A, Stocker R (1999) Tocopherol-mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement. FASEB J 13(9):977-994 (Pubitemid 29249724)
102. Veinbergs I, Mallory M, Sagara Y, Masliah E (2000) Vitamin E supplementation prevents spatial learning deficits and dendritic alterations in aged apolipoprotein E-deficient mice. Eur J Neurosci 12:4541-4546 (Pubitemid 32037862)
103. Vogiatzi G, Tousoulis D, Stefanadis C (2009) The role of oxidative stress in atherosclerosis. Hellenic J Cardiol 50(5):402-409
104. Wang J, Xiong S, Xie C, Markesbery WR, Lovell MA (2005) Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease. J Neurochem 93:953-962 (Pubitemid 40695754)
105. Watkins ML, Erickson JD, Thun MJ, Mulinare J, Heath CW Jr (2000) Multivitamin use and mortality in a large prospective study. Am J Epidemiol 152(2):149-162 (Pubitemid 30463663)
106. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, Schmidt AM (1996) RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382(6593):685-691 (Pubitemid 26282167)
107. Yochum LA, Folsom AR, Kushi LH (2000) Intake of antioxidant vitamins and risk of death from stroke in postmenopausal women. Am J Clin Nutr 72(2):476-483 (Pubitemid 30620655)
108. Zandi PP, Anthony JC, Khachaturian AS, Stone SV, Gustafson D, Tschanz JT et al (2004) Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the cache county study. Arch Neurol 61:82-88 (Pubitemid 38067418)
109. Zingg JM, Azzi A (2004) Non-antioxidant activities of vitamin E. Curr Med Chem 11(9):1113-1130